Form 4: Director Ackerman Reports Automatic Stock Conversion

Director John Ackerman reported the automatic conversion of Class B to Class A common stock for Guardian Pharmacy Services, Inc. through indirect holdings.

Summary

• John Ackerman, a Director of Guardian Pharmacy Services, Inc. (GRDN), reported changes in beneficial ownership.
• The transaction involved the automatic conversion of Class B common stock into Class A common stock on a one-for-one basis.
• This conversion occurred on September 27, 2025, and is part of a pre-defined schedule outlined in the Issuer's Amended and Restated Certificate of Incorporation.
• The filing reports the first of three substantially equal tranches of conversion, with subsequent tranches scheduled for March 28, 2026, and September 27, 2026.
• Through Pharmacy Investors, LLC, 1,413,940 shares of Class B common stock were converted, resulting in the acquisition of 1,413,940 shares of Class A common stock. Following this, Pharmacy Investors, LLC indirectly holds 1,863,564 Class A shares and 2,827,878 Class B shares.
• Through Cardinal Equity Fund, L.P., 471,057 shares of Class B common stock were converted, resulting in the acquisition of 471,057 shares of Class A common stock. Following this, Cardinal Equity Fund, L.P. indirectly holds 620,851 Class A shares and 942,114 Class B shares.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-scheduled automatic stock conversion, which is a mechanical event with no immediate positive or negative implications for the company's operational or financial performance.

Positives

• The transaction reflects the execution of a pre-defined capital structure plan, indicating adherence to established corporate governance mechanisms.

Negatives

• The filing does not present any inherently negative financial or operational developments.

Future Outlook

The company's Amended and Restated Certificate of Incorporation outlines future automatic conversions of Class B common stock into Class A common stock in substantially equal tranches on March 28, 2026, and September 27, 2026.

Industry Context

This Form 4 filing details a company-specific insider transaction related to a pre-scheduled stock conversion, which does not directly reflect broader industry trends or competitive dynamics.

Corporate Governance

Stakeholder Impact

• Shareholders holding Class B common stock will see their holdings automatically convert to Class A common stock, potentially affecting voting rights or liquidity depending on the specific terms of each class.

Next Steps

• The next tranche of automatic Class B to Class A common stock conversion is scheduled for March 28, 2026.
• The final tranche of automatic Class B to Class A common stock conversion is scheduled for September 27, 2026.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled automatic conversion of Class B common stock to Class A common stock for a director's indirect holdings. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment thesis. The transaction is a mechanical event stemming from existing corporate governance provisions.

Keywords

Guardian Pharmacy Services, GRDN, John Ackerman, Form 4, stock conversion, Class A common stock, Class B common stock, insider transaction, director holdings